Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Gossamer Bio (GOSS) Shares Outstanding (Diluted Average) (2022 - 2025)

Historic Shares Outstanding (Diluted Average) for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $228.0 million.

  • Gossamer Bio's Shares Outstanding (Diluted Average) rose 72.25% to $228.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $228.0 million, marking a year-over-year increase of 72.25%. This contributed to the annual value of $226.2 million for FY2024, which is 4822.8% up from last year.
  • According to the latest figures from Q3 2025, Gossamer Bio's Shares Outstanding (Diluted Average) is $228.0 million, which was up 72.25% from $227.3 million recorded in Q2 2025.
  • Gossamer Bio's Shares Outstanding (Diluted Average)'s 5-year high stood at $238.5 million during Q2 2024, with a 5-year trough of $75.9 million in Q1 2022.
  • Its 4-year average for Shares Outstanding (Diluted Average) is $164.2 million, with a median of $192.9 million in 2023.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first soared by 14992.22% in 2024, then plummeted by 472.35% in 2025.
  • Over the past 4 years, Gossamer Bio's Shares Outstanding (Diluted Average) (Quarter) stood at $84.6 million in 2022, then soared by 80.46% to $152.6 million in 2023, then soared by 48.23% to $226.2 million in 2024, then rose by 0.78% to $228.0 million in 2025.
  • Its last three reported values are $228.0 million in Q3 2025, $227.3 million for Q2 2025, and $226.8 million during Q1 2025.